title: The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading.
authors.affiliation: Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: O
authors.initials: O
authors.lastname: Pozdnyakova
authors.affiliation: Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Rodig
authors.affiliation: Sanofi Oncology, Cambridge, MA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Bhandarkar
authors.affiliation: Sanofi Oncology, Cambridge, MA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Wu
authors.affiliation: University of Cologne, Cologne, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Thiele
authors.affiliation: Massachusetts General Hospital, Boston, MA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Hasserjian
mesh_terms: D001706:Biopsy; D001853:Bone Marrow / Q000378:metabolism* / Q000473:pathology; D002986:Clinical Trials as Topic; D006801:Humans; D038622:Internationality; D012155:Reticulin / Q000378:metabolism*
chemical_list: D012155:Reticulin